S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 83.1 TWD 0.48% Market Closed
Market Cap: 9.9B TWD

SCI Pharmtech Inc
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Short-Term Debt
NT$100k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-46%
Y
YungShin Global Holding Corp
TWSE:3705
Short-Term Debt
NT$871.1m
CAGR 3-Years
-28%
CAGR 5-Years
-23%
CAGR 10-Years
0%
Formosa Laboratories Inc
TWSE:4746
Short-Term Debt
NT$733m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
1%
ScinoPharm Taiwan Ltd
TWSE:1789
Short-Term Debt
NT$35.6m
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
-30%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Short-Term Debt
NT$1.6B
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
13%
Standard Chem & Pharm Co Ltd
TWSE:1720
Short-Term Debt
NT$110m
CAGR 3-Years
-57%
CAGR 5-Years
-34%
CAGR 10-Years
-4%

SCI Pharmtech Inc
Glance View

Market Cap
9.9B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
58.86 TWD
Overvaluation 29%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Short-Term Debt?
Short-Term Debt
100k TWD

Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Short-Term Debt amounts to 100k TWD.

What is SCI Pharmtech Inc's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
-46%

Over the last year, the Short-Term Debt growth was -100%.

Back to Top